We should note that the lack of obvious changes to the nuclear localization of Anillin following tanespimycin treatment (Figs. 5C and S7A) could indicate that HSP90 inhibition perturbs Anillin’s role in cancer-associated gene transcription, rather than its cytoskeletal scaffolding function (82). The gene discussed is ANLN; the disease is cancer.